BOM/543245 (BOM/543245)

Bombay Stock Exchange: BOM/543245 · INR

₹3,047

+85.75 (+2.9%)· Recorded snapshot

Market cap	503B
Revenue (ttm)	67.3B
Net income (ttm)	11.3B
EPS (ttm)	₹68.4
P/E (trailing)	44.5x
P/E (forward)	36.0x
Dividend	₹20.0 (0.66%)
Volume	84,242

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 67.3B
Net income (ttm): 11.3B
EPS (ttm): ₹68.4
P/E (trailing): 44.5x
P/E (forward): 36.0x
Market cap: 503B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E36

P25 n/aP50 n/aP75 n/a

Trailing P/E44.5

P25 n/aP50 n/aP75 n/a

ROE10.5

P25 n/aP50 n/aP75 n/a

ROIC12.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BOM/543245 indicators

Market & fundamental data

Available fields

232

Groups with data

Currency

INR

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-11-06
Employees	4,332
Employees change	-19
Employees growth	-0.44%
Enterprise value	INR 472.2B
Exchange	Bombay Stock Exchange
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1978
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	INE068V01023
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Market cap	INR 503B
Next earnings date	2026-11-06
Price	INR 3,047.30
Price currency	INR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bom/543245
Website	https://www.glandpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	43.8x
Average P/E ratio (3Y)	39.04x
Average P/E ratio (5Y)	38.59x
Earnings yield	2.25%
EV/Earnings	41.83x
EV/EBIT	36.27x
EV/EBITDA	27.18x
EV/FCF	87.35x
EV/Sales	7.02x
FCF / EV yield	1.14%
FCF yield	1.07%
Forward P/E	36.02x
Graham number	982.64562
Graham upside	-67.75%
Industry forward P/E	33.04x
Industry P/E	38.96x
Lynch fair value	INR 341.94
Lynch upside	-88.78%
P/(FCF - SBC) ratio	101.58x
P/(OCF - SBC) ratio	51.02x
P/B ratio	4.86x
P/E ratio	44.54x
P/FCF ratio	93.04x
P/OCF ratio	48.77x
P/S ratio	7.48x
Price / tangible book value	5.05x
Price/EBITDA ratio	29.24x
Sector forward P/E	36.13x
Sector P/E	45.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.36%
EBITDA margin	25.58%
Effective tax rate	28.86%
FCF margin	8.41%
Gross margin	59.16%
Operating margin	19.36%
Pretax margin	23.59%
Profit margin	16.78%
Profit per employee	INR 2.6M
Profitable quarters	28
Profitable years	10
Revenue per employee	INR 15.5M
ROA	6.27%
ROA (5Y)	7.27%
ROCE	10.92%
ROE	10.53%
ROE (5Y)	11.3%
ROIC	12.72%
ROIC (5Y)	15.81%
SBC / revenue	0.71%
Tax / revenue	6.81%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	46.35%
EPS growth (Q)	46.94%
EPS growth (QoQ)	-13.54%
EPS growth 3Y	14.74%
EPS growth 5Y	1.22%
EPS growth quarters	5
EPS growth years	1
FCF growth	1.97%
FCF growth 3Y	55.77%
FCF growth 5Y	7.52%
Gross profit growth	20.48%
Gross profit growth (Q)	19.3%
Gross profit growth 3Y	24.3%
Gross profit growth 5Y	15.4%
Net income growth	46.55%
Net income growth (Q)	47.09%
Net income growth (QoQ)	-13.56%
Net income growth 3Y	14.81%
Net income growth 5Y	1.77%
Net income growth quarters	5
Net income growth years	1
OCF growth	12.75%
OCF growth 3Y	41.51%
OCF growth 5Y	11.26%
Operating income growth	34.73%
Operating income growth (Q)	41.77%
Operating income growth 3Y	14.31%
Operating income growth 5Y	1.21%
Revenue growth	17.57%
Revenue growth (Q)	19.57%
Revenue growth (QoQ)	3.3%
Revenue growth 3Y	19.14%
Revenue growth 5Y	12.5%
Revenue growth quarters	5
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -4.9B
Depreciation and amortization	INR 4.2B
EBIT	INR 13B
EBITDA	INR 17.2B
EPS	INR 68.41
Financing cash flow	INR -4.2B
Free cash flow	INR 5.4B
Free cash flow minus SBC	INR 5B
Gross profit	INR 39.8B
Income taxes	INR 4.6B
Investing cash flow	INR 1.4B
Net borrowing	INR -880.6M
Net cash flow	INR 8B
Net income	INR 11.3B
Operating cash flow minus SBC	INR 9.9B
Operating income	INR 13B
Revenue	INR 67.3B
Stock-based compensation	INR 454.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 628.68
Debt / EBITDA	0.16
Debt / equity	0.03
Debt / FCF	0.52
Interest coverage	58.07
Net cash (debt)	INR 30.8B
Net cash / market cap	6.11%
Net cash growth	16.56%
Net debt / EBITDA	-1.79
Net debt / equity	-0.3
Net debt / FCF	-5.69
Piotroski F-Score	6
Shareholders' equity	INR 103.6B
Tangible book value	INR 99.6B
Tangible book value per share	INR 604.25
Total cash	INR 33.6B
Total debt	INR 2.8B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current ratio	4.68
Inventory turnover	1.5
Quick ratio	3.41
Working capital	INR 59.2B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.14%
Dividend growth	11.11%
Dividend growth years	0
Dividend payment date	2026-09-24
Dividend payment years	3
Dividend payout frequency	Annual
Dividend per share	INR 20.00
Dividend yield	0.66%
Ex-dividend date	2026-08-11
Last dividend	INR 20.00
Payout ratio	29.23%
Shareholder yield	0.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	INR 2,427.14
1D price change	2.9%
1M price change	1.58%
1M total return	1.58%
1W price change	1.27%
1W total return	1.27%
1Y price change	54.45%
1Y return CAGR	55.67%
1Y total return	55.62%
20-day SMA	INR 2,988.97
200-day SMA	INR 2,260.13
3M price change	21.99%
3M total return	22.91%
3Y price change	91.11%
3Y return CAGR	25.21%
3Y total return	96.35%
50-day SMA	INR 2,933.33
50-day SMA vs 200-day SMA	50over200
52-week high	INR 3,171.00
52-week high date	2026-10-07
52-week low	INR 1,575.00
52-week low date	2026-03-16
5Y price change	-15.97%
5Y return CAGR	-2.9%
5Y total return	-13.66%
6M price change	67.01%
6M total return	68.27%
All-time high	INR 4,350.00
All-time high date	2021-08-12
All-time low	INR 861.50
All-time low date	2023-05-22
Average true range (ATR)	INR 101.49
Average volume	81.7K
Change from 52-week high	-3.9%
Change from 52-week low	93.48%
Change from all-time high	-31.92%
Change from all-time low	243.77%
Change from open	3.29%
Day's gap	-0.39%
Dollar volume	INR 256.7M
High price	INR 3,061.50
Low price	INR 2,922.75
Monthly RSI	72.58
Open price	INR 2,950.10
Position in 52-week range	89.77%
Previous close	INR 2,961.55
Price vs 150-day SMA	22.02%
Price vs 20-day SMA	-0.92%
Price vs 200-day SMA	31.03%
Price vs 50-day SMA	0.96%
Relative volume	1.03
RSI	57.08
Sharpe ratio	1.41
Sharpe ratio (3Y)	0.72
Sharpe ratio (5Y)	-0.01
Sortino ratio	2.96
Sortino ratio (3Y)	1.43
Sortino ratio (5Y)	0.14
Volume	84.2K
Weekly RSI	66.99
YTD price change	71.95%
YTD total return	73.25%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	89.5M
Shares change (QoQ)	-0.02%
Shares change (YoY)	0.14%
Shares held by insiders	0%
Shares held by institutions	36.27%

Deeper analysis on BOM/543245

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BOM/543245 report

Is a complete BOM/543245 research report available?

No complete published report is available for bom/543245 (BOM/543245) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BOM/543245 (BOM/543245)

Price

Financial snapshot

Fair-value bridge

Latest news · BOM/543245

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOM/543245 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BOM/543245

Frequently asked questions